153.63
-12.28
(-7.40%)
At close: 5:59:25 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 16 | 16 |
| Avg. Estimate | 5.49B | 5.64B | 22.83B | 24.03B |
| Low Estimate | 5.44B | 5.57B | 22.36B | 22.53B |
| High Estimate | 5.53B | 5.69B | 23.1B | 24.74B |
| Year Ago Sales | 5.14B | 5.41B | 21.55B | 22.83B |
| Sales Growth (year/est) | 6.65% | 4.23% | 5.89% | 5.29% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0KEF.L | -- | -- | -- | -- |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | Truist Securities: Hold to Hold | 4/4/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 4/3/2025 |
| Upgrade | HSBC: Hold to Buy | 3/31/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/28/2025 |
| Maintains | Citigroup: Buy to Buy | 3/24/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 3/19/2025 |